The cognitive effects presented by post-COVID-19 syndrome: A systematic review
DOI:
https://doi.org/10.33448/rsd-v12i6.40043Keywords:
Coronavirus; Syndrome; Sequels; Cognitive.Abstract
Introduction: Post-COVID-19 syndrome is the term applied to various symptoms, some cognitive, persistent, of COVID-19, even after the end of the acute phase of the infection. Objective: to present the cognitive effects of the post-COVID-19 syndrome through collected data and to analyze the relationship between SARS-CoV-2 infection and the development of these clinical manifestations. Methodology: a systematic literature review was performed, based on the search for clinical trials in PubMED and Scielo. Six studies were selected for review. Results: Overall, studies on the cognitive effects of post-COVID-19 syndrome were small and were based on tests and self-assessments, but show that mental confusion, memory loss and difficulty concentrating are the main complaints reported by patients. Discussion: Evidence points out that the cognitive effects of post-COVID-19 syndrome may be related to the severity of COVID-19 infection and previous neurological diseases. The relationship between viral diseases and cognitive effects is already well established, which makes it possible to think that COVID-19 is also capable of affecting the nervous system. The health system must prepare itself to face a great demand related to cognitive sequelae, being necessary to carry out reforms in its structure. Conclusion: the continuation of studies on the post-COVID-19 syndrome is essential for the understanding of a condition that is related to so many cognitive effects.
References
Asadi-Pooya, A. A., Akbari, A., Emami, A., Lotfi, M., Rostamihosseinkhani, M., Nemati, H., Barzegar, Z., Kabiri, M., Zeraatpisheh, Z., Farjoud-Kouhanjani, M., Jafari, A., Sasannia, F., Ashrafi, S., Nazeri, M., Nasiri, S., & Shahisavandi, M. (2021). Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iranian Journal of Medical Sciences, 46(6), 428–436. https://doi.org/10.30476/ijms.2021.92080.2326
Bardin, L. (1977). Análise de Conteúdo. Edições 70.
Berger, J. R., Moskowitz, L., Fischl, M., & Kelley, R. E. (1987). Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. Southern Medical Journal, 80(6), 683–686. https://doi.org/10.1097/00007611-198706000-00004
Bernardo, M. H. & Garbin, A. D. C. (2011). A atenção à saúde mental relacionada ao trabalho no SUS: desafios e possibilidades. Revista Brasileira de Saúde Ocupacional, 36(123), 103–117. https://www.scielo.br/j/rbso/a/Ym7kpRZmty9fFxPkLVg4hPC/?lang=pt
Boesl, F., Audebert, H., Endres, M., Prüss, H., & Franke, C. (2021). A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome - A Report on the Clinical Presentations of the First 100 Patients. Frontiers in Neurology, 12, 738405. https://doi.org/10.3389/fneur.2021.738405
Bonizzato, S., Ghiggia, A., Ferraro, F., & Galante, E. (2022). Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 43(1), 51–58. https://doi.org/10.1007/s10072-021-05653-w
Catalán, I. P., Martí, C. R., Sota, D. P., Álvarez, A. C., Gimeno, M. J. E., Juana, S. F., Rodríguez, G. H., Bajo, E. D., Gaya, N. T., Blasco, J. U., & Rincón, J. M. R. (2022). Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission. Journal of Medical Virology, 94(1), 205–210. https://doi.org/10.1002/jmv.27296
Chaumont, H., Meppiel, E., Roze, E., Tressières, B., de Broucker, T., Lannuzel, A., & contributors to the French NeuroCOVID registry (2022). Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients. Revue Neurologique, 178(1-2), 137–143. https://doi.org/10.1016/j.neurol.2021.12.008
Cordeiro, A. M., Oliveira, G. M. de ., Rentería, J. M., & Guimarães, C. A.. (2007). Revisão sistemática: uma revisão narrativa. Revista Do Colégio Brasileiro De Cirurgiões, 34(6), 428–431. https://doi.org/10.1590/S0100-69912007000600012
Crivelli, L., Calandri, I., Corvalán, N., Carello, M. A., Keller, G., Martínez, C., Arruabarrena, M., & Allegri, R. (2022). Cognitive consequences of COVID-19: results of a cohort study from South America. Arquivos de Neuro-psiquiatria, 80(3), 240–247. https://doi.org/10.1590/0004-282X-ANP-2021-0320
Fruchter, E., Goldberg, S., Fenchel, D., Grotto, I., Ginat, K., & Weiser, M. (2015). The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study. Schizophrenia Research, 168(1-2), 292–296. https://doi.org/10.1016/j.schres.2015.08.036
Leite, S. A. (2021). Reabilitação das funções mentais, cognitivas e psicológicas após quadro de COVID-19. In Universidade Aberta do SUS & Universidade Federal do Maranhão. Reabilitação do paciente com condições pós-covid. UNA-SUS UFMA.
Miranda, D. A. P., Gomes, S. V. C., Filgueiras, P. S., Corsini, C. A., Almeida, N. B. F., Silva, R. A., Medeiros, M. I. V. A. R. C., Vilela, R. V. R., Fernandes, G. R., & Grenfell, R. F. Q. (2022). Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 116(11), 1007–1014. https://doi.org/10.1093/trstmh/trac030
Novakovic-Agopians, T., & Abrams, G. M. (2014). Cognitive Rehabilitation Therapy. In J. A. Michael, & B. D. Robert (Eds.), Encyclopedia of the Neurological Sciences (2a ed., pp. 824-826). Academic Press.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Revista Española de Cardiología (English Edition), 74(9), 790–799. https://www.sciencedirect.com/science/article/pii/S1885585721002401?via%3Dihub.%20Acesso%20em:%2024%20jul.%202022
Santos, C. M. da C., Pimenta, C. A. de M., & Nobre, M. R. C.. (2007). The PICO strategy for the research question construction and evidence search. Revista Latino-americana De Enfermagem, 15(3), 508–511. https://doi.org/10.1590/S0104-11692007000300023
Schouten, J., Cinque, P., Gisslen, M., Reiss, P., & Portegies, P. (2011). HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25(5), 561-575. https://journals.lww.com/aidsonline/fulltext/2011/03130/hiv_1_infection_and_cognitive_impairment_in_the.3.aspx
Tabacof, L., Tosto-Mancuso, J., Wood, J., Cortes, M., Kontorovich, A., McCarthy, D., Rizk, D., Rozanski, G., Breyman, E., Nasr, L., Kellner, C., Herrera, J. E., & Putrino, D. (2022). Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. American Journal of Physical Medicine & Rehabilitation, 101(1), 48–52. https://doi.org/10.1097/PHM.0000000000001910
Tarter, K. D., Simanek, A. M., Dowd, J. B., & Aiello, A. E. (2014). Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. The Journal of Infectious Diseases, 209(6), 837–844. https://doi.org/10.1093/infdis/jit616
Venkatesan, P. (2021). NICE guideline on long COVID. The Lancet Respiratory Medicine, 9(2), 129. https://doi.org/10.1016/S2213-2600(21)00031-X
Wilson, B. A. (2008). Neuropsychological rehabilitation. Annual Review of Clinical Psychology, 4, 141–162. https://doi.org/10.1146/annurev.clinpsy.4.022007.141212
World Health Organization. (2020, March 11). WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---11-march-2020
World Health Organization. (2021, December 4). Coronavirus disease (COVID-19): Variants of SARS-COV-2. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-%28COVID-19%29-variants-of-sars-cov-2?gclid=Cj0KCQjw2_OWBhDqARIsAAUNTTF4siZKsvbA2ZfvAtEdFFBOE-Gk1aaMWNHof2CxriWU6Dj4H_vHFD0aAmNoEALw_wcB
World Health Organization. (2022, June 17). Interim statement on the composition of current COVID-19 vaccines. https://www.who.int/news/item/17-06-2022-interim-statement-on--the-composition-of-current-COVID-19-vaccines
World Health Organization. (n.d.). Coronavirus disease (COVID-19). https://www.who.int/health-topics/coronavirus#tab=tab_1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Adna Jwklezya de Santana; Clayrton de Barros Pereira; Fernanda Teixeira de Andrade ; Gabriel Malvezzi da Silva Pinto; Giovana Dutra Marques; Nilton Nascimento dos Santos Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.